CN112691147A - Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof Download PDFInfo
- Publication number
- CN112691147A CN112691147A CN202110040009.5A CN202110040009A CN112691147A CN 112691147 A CN112691147 A CN 112691147A CN 202110040009 A CN202110040009 A CN 202110040009A CN 112691147 A CN112691147 A CN 112691147A
- Authority
- CN
- China
- Prior art keywords
- parts
- shoulder pain
- stroke
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, an external medicine and a preparation method thereof, and particularly relates to the field of traditional Chinese medicine compositions. The invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, which comprises the following components in parts by mass: 30-60 parts of caulis spatholobi, 30-60 parts of Chinese starjasmine stem, 30-60 parts of caulis sinomenii, 30-60 parts of kadsura pepper stem, 30-60 parts of lycopodium clavatum, 30-60 parts of safflower, 30-60 parts of honeysuckle, 30-60 parts of radix scrophulariae and 10-20 parts of ground beetle. The traditional Chinese medicine composition can effectively treat shoulder pain after stroke. The external medicine prepared from the components has the advantages of remarkable treatment effect, short treatment period, effect taking after 1-2 treatment courses and simple preparation method.
Description
Technical Field
The invention relates to the field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating shoulder pain after stroke, an external medicine and a preparation method thereof.
Background
The main causes of shoulder pain after stroke are closely related to qi deficiency, qi stagnation, blood deficiency, blood stasis, wind, cold and dampness, and the key pathogenesis of the shoulder pain is qi and blood deficiency, loss of soft-support of extremities, and pain caused by insufficient nourishment, or qi deficiency pushing weakness, blood stasis internal stop, yang qi deficiency, wind-cold-dampness pathogen attacking the outside, obstruction of shoulder tendons and collaterals, and pain caused by obstruction. For treatment, it should tonify qi and nourish blood, activate blood and resolve stasis, expel wind and remove cold, warm yang and remove dampness, promote qi circulation and alleviate pain.
At present, a plurality of methods for treating neck and shoulder pain exist in western medicine, but although the medical methods can temporarily relieve pain aiming at diseases, the medical methods have the defects of limitation on treatment and insufficient curative effect.
Disclosure of Invention
In order to solve the problems, the invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, an external medicine and a preparation method thereof. The traditional Chinese medicine composition can effectively treat shoulder pain after stroke.
In order to achieve the above purpose, the invention provides the following technical scheme:
the invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, which comprises the following components in parts by mass: 30-60 parts of caulis spatholobi, 30-60 parts of Chinese starjasmine stem, 30-60 parts of caulis sinomenii, 30-60 parts of kadsura pepper stem, 30-60 parts of lycopodium clavatum, 30-60 parts of safflower, 30-60 parts of honeysuckle, 30-60 parts of radix scrophulariae and 10-20 parts of ground beetle.
Preferably, the traditional Chinese medicine composition comprises the following components in parts by mass: 50 parts of caulis spatholobi, 50 parts of Chinese starjasmine stem, 50 parts of caulis sinomenii, 50 parts of kadsura pepper stem, 50 parts of lycopodium clavatum, 50 parts of safflower, 50 parts of honeysuckle, 50 parts of radix scrophulariae and 15 parts of ground beetle.
Preferably, the post-stroke shoulder pain comprises qi deficiency and blood stasis type post-stroke shoulder pain, phlegm-dampness stagnation type post-stroke shoulder pain, yang deficiency and congealing cold type post-stroke shoulder pain and yin deficiency and blood stasis type post-stroke shoulder pain.
Preferably, when the post-stroke shoulder pain is qi deficiency and blood stasis type post-stroke shoulder pain, the traditional Chinese medicine composition further comprises 30-60 parts of astragalus;
when the post-stroke shoulder pain is phlegm-damp collateral blocking syndrome type post-stroke shoulder pain, the composition further comprises 30-60 parts of bighead atractylodes rhizome;
when the post-stroke shoulder pain is post-stroke shoulder pain caused by yang deficiency and congealing cold, the traditional Chinese medicine composition further comprises 30-60 parts of folium artemisiae argyi;
when the post-stroke shoulder pain is post-stroke shoulder pain caused by yin deficiency and blood stasis, the traditional Chinese medicine composition further comprises 30-60 parts of white paeony root.
Preferably, when the composition comprises astragalus, the dosage of the astragalus is 60 parts;
when the composition also comprises the white atractylodes rhizome, the using amount of the white atractylodes rhizome is 60 parts;
when the composition also comprises folium artemisiae argyi, the using amount of the folium artemisiae argyi is 60 parts;
when the composition further comprises white peony root, the amount of white peony root is 60 parts.
The invention provides an external medicine for treating shoulder pain after stroke, and the effective components of the external medicine comprise the traditional Chinese medicine composition.
Preferably, the topical formulation includes a buccal tablet.
The invention provides a preparation method of the external medicine, which comprises the following steps:
pulverizing the raw materials of the traditional Chinese medicine composition, mixing with vaseline, and coating on gauze; the mass ratio of the raw materials to the vaseline is 1: 3-5.
Preferably, the crushed particle size is 100 to 200 meshes.
Preferably, the thickness of the coating is 0.5-1 cm.
Has the advantages that: the invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, which comprises 30-60 parts of caulis spatholobi, 30-60 parts of Chinese starjasmine stem, 30-60 parts of caulis sinomenii, 30-60 parts of kadsura pepper stem, 30-60 parts of lycopodium clavatum, 30-60 parts of safflower, 30-60 parts of honeysuckle, 30-60 parts of radix scrophulariae and 10-20 parts of ground beetle. In the traditional Chinese medicine composition, honeysuckle, safflower, figwort root and ground beeltle are used as monarch drugs for detoxifying and removing blood stasis; the caulis spatholobi, the caulis trachelospermi, the caulis sinomenii, the caulis piperis futokadsurae and the lycopodium clavatum are used as ministerial drugs for relaxing muscles and tendons, dredging collaterals and relieving arthralgia and pain, thereby fundamentally solving the problem of shoulder pain of patients.
The external medicine prepared by the components has the effect of treating shoulder pain after stroke. The experimental results show that: the external medicine has obvious effect on the pain of patients suffering from shoulder pain after stroke with syndrome of qi deficiency and blood stasis, shoulder pain after stroke with syndrome of phlegm-dampness blocking collaterals, shoulder pain after stroke with syndrome of yang deficiency and congealing cold and shoulder pain after stroke with syndrome of yin deficiency and blood stasis, has short treatment period, and can take effect after 1-2 treatment courses.
The invention provides a preparation method of the external medicine, which is simple and feasible and has low cost.
Detailed Description
The Chinese medicinal components of the invention are obtained by conventional purchase by those skilled in the art without special requirements.
The invention provides a traditional Chinese medicine composition for treating shoulder pain after stroke, which comprises the following components in parts by mass: 30-60 parts of caulis spatholobi, 30-60 parts of Chinese starjasmine stem, 30-60 parts of caulis sinomenii, 30-60 parts of kadsura pepper stem, 30-60 parts of lycopodium clavatum, 30-60 parts of safflower, 30-60 parts of honeysuckle, 30-60 parts of radix scrophulariae and 10-20 parts of ground beeltle, preferably 35-55 parts of caulis spatholobi, 35-55 parts of Chinese starjasmine stem, 35-55 parts of caulis sinomenii, 35-55 parts of kadsura pepper stem, 35-55 parts of lycopodium clavatum, 35-55 parts of safflower, 35-55 parts of honeysuckle, 35-55 parts of radix scrophulariae and 11-28 parts of ground beeltle, more preferably 50 parts of caulis spatholobi, 50 parts of caulis trachelospermi, 50 parts of caulis sinomenii, 50 parts of kadsura pepper stem, 50 parts of lycopodium clavatum, 50 parts of safflower, 50 parts of honeysuckle, 50 parts of radix scrophulariae and 15. After stroke, shoulder pain occurs and toxic stasis is blocked on shoulders, and honeysuckle, safflower, figwort root and ground beeltle are used as monarch drugs for detoxifying and removing blood stasis in the traditional Chinese medicine composition; the Chinese medicinal composition is prepared from caulis spatholobi, caulis trachelospermi, caulis sinomenii, caulis piperis futokadsurae and lycopodium clavatum, and is used for relaxing tendons, dredging collaterals and relieving arthralgia.
In the present invention, the post-stroke shoulder pain preferably includes qi deficiency and blood stasis type post-stroke shoulder pain, phlegm-dampness stagnation type post-stroke shoulder pain, yang deficiency and congealing cold type post-stroke shoulder pain, and yin deficiency and blood stasis type post-stroke shoulder pain.
In the invention, when the post-stroke shoulder pain is qi deficiency and blood stasis type post-stroke shoulder pain, the traditional Chinese medicine composition preferably further comprises 30-60 parts of astragalus membranaceus, and the using amount of the astragalus membranaceus is more preferably 35-55 parts, and most preferably 50 parts. In the invention, honeysuckle flower, safflower, figwort root and ground beeltle in the traditional Chinese medicine composition are used as monarch drugs for detoxifying and removing blood stasis; caulis Spatholobi, caulis Trachelospermi, caulis Sinomenii, caulis Piperis Kadsurae, and herba Lycopodii are used as ministerial drugs for relaxing muscles and tendons, dredging collaterals, and relieving arthralgia and pain; the astragalus root is taken as an adjuvant drug for benefiting qi and assisting blood stasis; the traditional Chinese medicine composition has the effects of tonifying qi and removing blood stasis.
In the invention, when the post-stroke shoulder pain is phlegm-dampness blocking collateral syndrome type post-stroke shoulder pain, the composition further comprises 30-60 parts of bighead atractylodes rhizome, and the using amount of the bighead atractylodes rhizome is more preferably 35-55 parts, and most preferably 50 parts. In the invention, honeysuckle flower, safflower, figwort root and ground beeltle in the traditional Chinese medicine composition are used as monarch drugs for detoxifying and removing blood stasis; caulis Spatholobi, caulis Trachelospermi, caulis Sinomenii, caulis Piperis Kadsurae, and herba Lycopodii are used as ministerial drugs for relaxing muscles and tendons, dredging collaterals, and relieving arthralgia and pain; rhizoma atractylodis macrocephalae is used as an adjuvant drug for tonifying spleen and eliminating dampness; the traditional Chinese medicine composition has the effects of eliminating dampness and removing blood stasis.
In the invention, when the post-stroke shoulder pain is post-stroke shoulder pain caused by yang deficiency and congealing cold, the traditional Chinese medicine composition further comprises 30-60 parts of folium artemisiae argyi, and the using amount of the folium artemisiae argyi is more preferably 35-55 parts, and most preferably 50 parts. In the invention, honeysuckle flower, safflower, figwort root and ground beeltle in the traditional Chinese medicine composition are used as monarch drugs for detoxifying and removing blood stasis; caulis Spatholobi, caulis Trachelospermi, caulis Sinomenii, caulis Piperis Kadsurae, and herba Lycopodii are used as ministerial drugs for relaxing muscles and tendons, dredging collaterals, and relieving arthralgia and pain; folium artemisiae argyi is used as an adjuvant drug for warming and activating meridians; the traditional Chinese medicine composition provided by the invention has the effects of warming channels, dredging collaterals and removing blood stasis.
In the invention, when the post-stroke shoulder pain is post-stroke shoulder pain caused by yin deficiency and blood stasis, the traditional Chinese medicine composition further comprises 30-60 parts of white paeony root, and the using amount of the white paeony root is more preferably 35-55 parts, and most preferably 50 parts. In the invention, honeysuckle flower, safflower, figwort root and ground beeltle in the traditional Chinese medicine composition are used as monarch drugs for detoxifying and removing blood stasis; caulis Spatholobi, caulis Trachelospermi, caulis Sinomenii, caulis Piperis Kadsurae, and herba Lycopodii are used as ministerial drugs for relaxing muscles and tendons, dredging collaterals, and relieving arthralgia and pain; white peony root is used as adjuvant drug for nourishing yin and blood; the traditional Chinese medicine composition has the effects of nourishing yin and removing blood stasis.
The traditional Chinese medicine composition has the effects of detoxifying and removing blood stasis, and has a remarkable curative effect on patients with shoulder pain after stroke. The medicine is added and subtracted on the aspect of syndrome differentiation, astragalus is added for qi deficiency and blood stasis syndrome to tonify qi and remove blood stasis, bighead atractylodes rhizome is added for spleen strengthening and phlegm reduction for phlegm-damp obstruction of collaterals, folium artemisiae argyi is added for warming channels and dredging collaterals for yang deficiency and cold coagulation syndrome, and radix paeoniae alba is added for yin deficiency and blood stasis syndrome to nourish yin and activate blood.
The invention provides an external medicine for treating shoulder pain after stroke, and the effective components of the external medicine comprise the traditional Chinese medicine composition. Preferably, the formulation of the topical preparation of the invention comprises a buccal tablet. Using the swamp digital camera for 1 time per day, 30min each time, and 1 treatment course for 2 weeks; can take effect after 1-2 treatment courses.
The invention provides a preparation method of the external medicine, which comprises the following steps:
pulverizing the raw materials of the traditional Chinese medicine composition, mixing with vaseline, and coating on gauze; the mass ratio of the raw materials to the vaseline is preferably 1: 3-5, and more preferably 1: 5. In the invention, the particle size of the crushed particles is preferably 100-200 meshes, and more preferably 200 meshes; the thickness of the coating is preferably 0.5-1 cm, and more preferably 0.6-0.9 cm. In the invention, the vaseline is added to fully mix and form the disease-protecting medicine.
The invention also provides a method for treating shoulder pain after stroke by using the externally applied medicine, which preferably comprises the step of heating the externally applied medicine to 40 ℃ and externally applying the externally applied medicine to the shoulders of a patient. The heating mode of the invention is preferably visible light irradiation; the visible light irradiation instrument is preferably a physiotherapy instrument; the name of the physical therapy instrument is preferably a specific electromagnetic wave therapeutic instrument; the merchantable name of the specific electromagnetic wave therapeutic apparatus is preferably Meihui Shen lamp, the name of a production enterprise is preferably Chongqing Bo John technology Limited, and the product number is preferably OH-LJ. In the present invention, the standard of the external application is preferably that gauze completely covers the shoulder of the patient.
In the present invention, said applying on the shoulder of the patient preferably further comprises heating the shoulder of the patient. In the invention, the distance between the heated physiotherapy instrument and the skin of a patient is preferably 20-30 cm; the temperature of the heating is preferably subject to patient tolerance.
For further illustration of the present invention, the following examples are provided to describe the Chinese medicinal composition for treating shoulder pain after stroke, the external preparation and the preparation method thereof in detail, but they should not be construed as limiting the scope of the present invention.
Example 1
Preparing components: 50g of caulis spatholobi, 50g of Chinese starjasmine stem, 50g of caulis sinomenii, 50g of kadsura pepper stem, 50g of lycopodium clavatum, 50g of safflower, 50g of honeysuckle, 50g of figwort root and 15g of ground beetle.
Preparing the traditional Chinese medicine collapsed tablets:
grinding the components to 200 meshes, mixing with vaseline uniformly, and applying the mixture on a single-layer gauze according to the mass ratio of the medicinal powder to the vaseline of 1:5 to keep the thickness of the collapsed ointment between 0.5cm and 1 cm.
Example 2
Preparing components: 50g of astragalus mongholicus, 50g of caulis spatholobi, 50g of Chinese starjasmine stem, 50g of caulis sinomenii, 50g of kadsura pepper stem, 50g of lycopodium clavatum, 50g of safflower carthamus, 50g of honeysuckle, 50g of radix scrophulariae and 15g of ground beetle.
The preparation process of the traditional Chinese medicine collapsed tablet is the same as that of the example 1.
Example 3
Preparing components: 50g of largehead atractylodes rhizome, 50g of suberect spatholobus stem, 50g of Chinese starjasmine stem, 50g of caulis sinomenii, 50g of kadsura pepper stem, 50g of common clubmoss herb, 50g of safflower, 50g of honeysuckle flower, 50g of figwort root and 15g of ground beetle.
The preparation process of the traditional Chinese medicine collapsed tablet is the same as that of the example 1.
Example 4
Preparing components: 50g of folium artemisiae argyi, 50g of caulis spatholobi, 50g of Chinese starjasmine stem, 50g of caulis sinomenii, 50g of kadsura pepper stem, 50g of lycopodium clavatum, 50g of safflower, 50g of honeysuckle, 50g of radix scrophulariae and 15g of ground beetle.
The preparation process of the traditional Chinese medicine collapsed tablet is the same as that of the example 1.
Example 5
Preparing components: 50g of white peony root, 50g of caulis spatholobi, 50g of Chinese starjasmine stem, 50g of caulis sinomenii, 50g of kadsura pepper stem, 50g of lycopodium clavatum, 50g of safflower, 50g of honeysuckle, 50g of figwort root and 15g of ground beetle.
The preparation process of the traditional Chinese medicine collapsed tablet is the same as that of the example 1.
Application example 1
1. Criteria for selecting cases
1.1 inclusion criteria
(1) The diagnosis standard of western medicine and traditional Chinese medicine of apoplexy is met;
(2) unilateral shoulder pain, flushing of the skin, elevated or insignificant skin temperature; unilateral shoulder swelling, limited mobility;
(3) the course of disease is within 6 months;
(4) the age is 35-70 years old;
(5) conscious consciousness and steady vital signs;
(6) the principal or family signs an informed consent.
1.2 exclusion criteria
(1) Eliminating shoulder pain caused by non-apoplexy diseases such as trauma, infection, peripheral angiopathy, etc.;
(2) severe cognitive impairment, sensory impairment, mental impairment, inability to coordinate examination and treatment;
(3) skin breakdown and skin allergies;
(4) patients with serious primary diseases such as liver, kidney, hemopoietic system and endocrine system;
(5) pregnant and lactating women;
(6) unstable vital signs.
1.3 diagnostic criteria
1.3.1 Western diagnostic standards
All cases were diagnosed by CT or MRI according to the diagnosis standards of cerebral infarction and cerebral hemorrhage in Chinese acute ischemic stroke diagnosis and treatment guideline and Chinese cerebral hemorrhage diagnosis and treatment guideline formulated by neurology division cerebrovascular disease group of Chinese medical society in 2018.
Cerebral infarction diagnosis standard:
(1) acute onset of disease;
(2) focal neurological deficit (weakness or numbness of one side or limbs, speech disturbance, etc.), rarely seen as general neurological deficit;
(3) the duration of symptoms or signs is not limited (when imaging shows a responsible ischemic lesion), or lasts more than 24h (when there is no imaging responsible lesion);
(4) excluding non-vascular causes;
(5) brain CT/MRI excluded cerebral hemorrhage.
Cerebral hemorrhage diagnosis can be based on:
(1) acute onset of disease;
(2) focal neurological deficit symptoms (a minority of them are general neurological deficit) often associated with headache, vomiting, elevated blood pressure and different degrees of disturbance of consciousness;
(3) cranial CT or MRI show foci of bleeding;
(4) excluding non-vascular brain causes.
1.3.2 Chinese medicine diagnostic Standard
Refer to the diagnosis and treatment guideline for common diseases in internal medicine of traditional Chinese medicine (ZYXH/T19-2008) published by the Chinese society for traditional Chinese medicine.
The main symptoms are: hemiplegia, coma, slurred speech, abnormal sensation of the body, and facial and lingual deflection.
Secondary symptoms: headache, vertigo, mydriasis, choking of drinking water, impaired vision and ataxia.
Acute onset usually has a predisposing cause before onset, and a premonitory symptom is usually observed.
The onset age is usually 40 years or older.
The diagnosis can be confirmed by more than 2 main symptoms, or 1 main symptom and 2 secondary symptoms, combined with onset, induction, premonitory symptoms and age; without the above conditions, the diagnosis can be confirmed by combining the results of the imaging examination.
4. Pain visual simulation score
Level 0: no pain; grade 1-3: mild pain (sleep is not affected); 4-6 level: moderate pain (sleep affected); 7-10 level: severe pain (severely affecting sleep).
5. Treatment regimens
Clinical trials were conducted by administering the herbal swamp sheets prepared in examples 2-5 of the present invention to the patient, followed by irradiation with specific electromagnetic wave therapy apparatus, and the treatment was carried out 1 time per day for 30min each time until pain was alleviated or the study was completed.
6. Study subjects: the experiment totally counts 20 post-stroke shoulder pain patients, wherein the post-stroke shoulder pain is 7 post-stroke shoulder pain patients with qi deficiency and blood stasis syndrome, the traditional Chinese medicine inula flakes prepared in the external application example 2 are applied to 9 post-stroke shoulder pain patients with phlegm-dampness blocking collateral syndrome, the traditional Chinese medicine inula flakes prepared in the external application example 3 are applied to 2 post-stroke shoulder pain patients with yang deficiency and congealing cold syndrome, the traditional Chinese medicine inula flakes prepared in the external application example 4 are applied to 2 post-stroke shoulder pain patients with yin deficiency and blood stasis syndrome, and the traditional Chinese medicine inula flakes prepared in the external application example 5 are applied to 2 post-stroke shoulder pain patients with yin deficiency and blood stasis syndrome.
TABLE 1 therapeutic Effect
The test data recorded in table 1 show that the traditional Chinese medicine composition and the external medicine thereof provided by the invention can remarkably relieve the pain of patients suffering from shoulder pain after stroke due to qi deficiency and blood stasis, phlegm-dampness and collateral obstruction, yang deficiency and congealing cold and yin deficiency and blood stasis, so that the traditional Chinese medicine composition and the external medicine thereof can treat and improve the shoulder pain after stroke.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (10)
1. The traditional Chinese medicine composition for treating shoulder pain after stroke is characterized by comprising the following components in parts by mass: 30-60 parts of caulis spatholobi, 30-60 parts of Chinese starjasmine stem, 30-60 parts of caulis sinomenii, 30-60 parts of kadsura pepper stem, 30-60 parts of lycopodium clavatum, 30-60 parts of safflower, 30-60 parts of honeysuckle, 30-60 parts of radix scrophulariae and 10-20 parts of ground beetle.
2. The traditional Chinese medicine composition as claimed in claim 1, wherein the traditional Chinese medicine composition comprises the following components in parts by mass: 50 parts of caulis spatholobi, 50 parts of Chinese starjasmine stem, 50 parts of caulis sinomenii, 50 parts of kadsura pepper stem, 50 parts of lycopodium clavatum, 50 parts of safflower, 50 parts of honeysuckle, 50 parts of radix scrophulariae and 15 parts of ground beetle.
3. The Chinese medicinal composition according to claim 1 or 2, wherein the post-stroke shoulder pain comprises post-stroke shoulder pain due to qi deficiency and blood stasis, post-stroke shoulder pain due to phlegm-dampness obstructing the collaterals, post-stroke shoulder pain due to yang deficiency and congealing cold, and post-stroke shoulder pain due to yin deficiency and blood stasis.
4. The traditional Chinese medicine composition as claimed in claim 3, wherein when the post-stroke shoulder pain is post-stroke shoulder pain of qi deficiency and blood stasis syndrome, the traditional Chinese medicine composition further comprises 30-60 parts of radix astragali;
when the post-stroke shoulder pain is phlegm-damp collateral blocking syndrome type post-stroke shoulder pain, the composition further comprises 30-60 parts of bighead atractylodes rhizome;
when the post-stroke shoulder pain is post-stroke shoulder pain caused by yang deficiency and congealing cold, the traditional Chinese medicine composition further comprises 30-60 parts of folium artemisiae argyi;
when the post-stroke shoulder pain is post-stroke shoulder pain caused by yin deficiency and blood stasis, the traditional Chinese medicine composition further comprises 30-60 parts of white paeony root.
5. The Chinese medicinal composition according to claim 6, wherein when the composition comprises astragalus, the astragalus is used in an amount of 60 parts;
when the composition also comprises the white atractylodes rhizome, the using amount of the white atractylodes rhizome is 60 parts;
when the composition also comprises folium artemisiae argyi, the using amount of the folium artemisiae argyi is 60 parts;
when the composition further comprises white peony root, the amount of white peony root is 60 parts.
6. An external medicine for treating shoulder pain after stroke, which is characterized in that the effective component of the external medicine comprises the traditional Chinese medicine composition as claimed in any one of claims 1 to 5.
7. The topical for application according to claim 6, in a dosage form comprising a biopestin.
8. The method for producing an external preparation for external use as claimed in claim 6 or 7, characterized by comprising the steps of:
pulverizing the raw materials of the traditional Chinese medicine composition, mixing with vaseline, and coating on gauze; the mass ratio of the raw materials to the vaseline is 1: 3-5.
9. The method according to claim 8, wherein the pulverized particle size is 100 to 200 mesh.
10. The method of claim 6, wherein the coating has a thickness of 0.5 to 1 cm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110040009.5A CN112691147A (en) | 2021-01-13 | 2021-01-13 | Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110040009.5A CN112691147A (en) | 2021-01-13 | 2021-01-13 | Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112691147A true CN112691147A (en) | 2021-04-23 |
Family
ID=75514267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110040009.5A Pending CN112691147A (en) | 2021-01-13 | 2021-01-13 | Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112691147A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114652587A (en) * | 2022-03-23 | 2022-06-24 | 长春中医药大学 | Physical therapy medium and using method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101632737A (en) * | 2008-07-23 | 2010-01-27 | 吉林一正药业集团有限公司 | Medicament for relieving pain of human body and preparation method thereof |
| CN110876782A (en) * | 2019-11-29 | 2020-03-13 | 辛永顺 | Swelling-diminishing pain-relieving gout soup |
| CN110898144A (en) * | 2019-11-29 | 2020-03-24 | 菏泽市圣医医疗科技有限公司 | Black plaster for treating scapulohumeral periarthritis and preparation method thereof |
-
2021
- 2021-01-13 CN CN202110040009.5A patent/CN112691147A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101632737A (en) * | 2008-07-23 | 2010-01-27 | 吉林一正药业集团有限公司 | Medicament for relieving pain of human body and preparation method thereof |
| CN110876782A (en) * | 2019-11-29 | 2020-03-13 | 辛永顺 | Swelling-diminishing pain-relieving gout soup |
| CN110898144A (en) * | 2019-11-29 | 2020-03-24 | 菏泽市圣医医疗科技有限公司 | Black plaster for treating scapulohumeral periarthritis and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 无: "[吉林省]DB22/T3216-2020中风后肩痛的中药塌渍治疗技术规范", 《HTTP://MY678.CN/T-280957-1-1.HTML》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114652587A (en) * | 2022-03-23 | 2022-06-24 | 长春中医药大学 | Physical therapy medium and using method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102335326B (en) | Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain | |
| CN104523865B (en) | Medicine for treating breast diseases | |
| CN103705878B (en) | One treats migraine Chinese medicine preparation | |
| CN112691147A (en) | Traditional Chinese medicine composition for treating shoulder pain after stroke, external medicine and preparation method thereof | |
| CN105079184A (en) | Medicine for treating osteoporosis | |
| CN101874850A (en) | Medicament for treating chronic urticaria | |
| CN101543616A (en) | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method | |
| CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
| CN112755169A (en) | Traditional Chinese medicine plaster for treating rheumatic ostealgia | |
| CN105770251A (en) | Tongning capsule for treatment of cervical spondylosis, lumbar diseases and arthritis | |
| CN103948713A (en) | Traditional Chinese medicinal composition for treating hypertension | |
| CN115120690B (en) | Traditional Chinese medicine composition for treating precocious puberty and application thereof | |
| CN107595998B (en) | Traditional Chinese medicine composition for stroke convalescence and preparation method thereof | |
| CN107050333B (en) | Granules for treating ankylosing spondylitis | |
| CN105412244A (en) | Traditional Chinese medicine composition treating gynecological cervicitis | |
| CN105232661A (en) | Traditional Chinese medicine composition for treating mastitis and preparation method thereof | |
| CN111491650A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN115429869A (en) | Traditional Chinese medicine composition for treating cold-dampness arthralgia-syndrome type lumbago and preparation method thereof | |
| CN104547862A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating bone fracture | |
| CN104001031A (en) | Medicament for treating asthma | |
| CN112972561A (en) | A Chinese medicinal composition for treating hyperosteogeny, and its preparation method | |
| CN104352968A (en) | Drug for treating cervical spondylosis and lumbar spondylosis and preparation method thereof | |
| CN103736016B (en) | A kind of medicine for the treatment of cyclomastopathy and preparation method thereof | |
| CN102366510A (en) | Traditional Chinese medicine for treating hypercortisolism | |
| CN103920099A (en) | Medicine composition for treating chronic cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |